Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Furiex Pharmaceuticals, Inc
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Clinical diagnosis of a complicated skin and skin structure infection (cSSSI) including wound infection, deep cellulitis or severe abscess
Women of childbearing potential must agree to use an acceptable form of contraception
Infection site offers ability to obtain a microbiological specimen
Received only 1 dose of any potentially effective systemic antibiotic within 24 hours of beginning study treatment
You may not be if
History of hypersensitivity or allergic reaction to quinolones or to linezolid
Female and pregnant or breastfeeding or may be pregnant
Chronic or underlying skin condition surrounding the area of infection that may complicate the assessment of response (e.g. atopic dermatitis, eczema, or psoriasis)
Subject has infections with a high cure rate after surgical incision alone after aggressive local skin care
Subject has infection(s) suspected to be caused by Gram-negative rods, anaerobic bacteria or unusual pathogens
Subject has an infection that is expected to require other antifungal, antimycobacterial, or antibacterial agents in addition to study medication
Other protocol-specific eligibility criteria may apply
